⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1648584 | 0.87 | — | — | |
| SCHEMBL3174288 | 0.77 | — | — | |
| SCHEMBL4129218 | 0.75 | — | — | |
| SCHEMBL18282347 | 0.73 | TSHR (0.33) | — | |
| SCHEMBL3457354 | 0.73 | TSHR (0.33) | — | |
| SCHEMBL716409 | 0.71 | — | — | |
| SCHEMBL1840595 | 0.71 | — | — | |
| SCHEMBL4393734 | 0.71 | — | — | |
| SCHEMBL3435999 | 0.71 | — | — | |
| SCHEMBL31189768 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2514013-A2 | HIGH ENERGY DENSITY REDOX FLOW DEVICE | Massachusetts Institute of Technology (US) | 2012-10-24 | — | — | EP | claimed |
| WO-2011084649-A2 | HIGH ENERGY DENSITY REDOX FLOW DEVICE | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2011-07-14 | — | — | WO | claimed |
| EP-1228059-B1 | NOVEL CYCLOPROPANES AS CGRP ANTAGONISTS, MEDICAMENTS CONTAINING SAID COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF | BOEHRINGER INGELHEIM PHARMA (DE) | 2005-08-03 | — | — | EP | claimed |
| EP-4213627-A1 | STABILIZATION OF THIOKETONES ON SURFACES | Bayer Aktiengesellschaft (DE) | 2023-07-26 | — | — | EP | disclosed |
| WO-2022058522-A1 | STABILIZATION OF THIOKETONES ON SURFACES | BAYER AKTIENGESELLSCHAFT (DE) | 2022-03-24 | — | — | WO | disclosed |
| EP-3941199-A1 | STABILIZED THIOKETONE FORMULATIONS | Bayer Aktiengesellschaft (DE) | 2022-01-26 | — | — | EP | disclosed |
| WO-2020187871-A1 | STABILIZED THIOKETONE FORMULATIONS | BAYER AKTIENGESELLSCHAFT (DE) | 2020-09-24 | — | — | WO | disclosed |
| EP-3638034-A1 | STABILISED FORMULATIONS CONTAINING PROTHIOCONAZOLE WITH A LOW 2-(1-CHLOROCYCLOPROPYL)-1-(2-CHLOROPHENYL)-3-(1H-1,2,4-TRIAZOL-1-YL)PROPAN-2-OL CONTENT | Bayer Aktiengesellschaft (DE) | 2020-04-22 | — | — | EP | disclosed |
| WO-2018228885-A1 | STABILISED FORMULATIONS CONTAINING PROTHIOCONAZOLE WITH A LOW 2-(1-CHLOROCYCLOPROPYL)-1-(2-CHLOROPHENYL)-3-(1H-1,2,4-TRIAZOL-1-YL)PROPAN-2-OL CONTENT | BAYER AKTIENGESELLSCHAFT (DE) | 2018-12-20 | — | — | WO | disclosed |
| EP-3386300-A1 | LIQUID FORMULATIONS CONTAINING PROTHIOCONAZOLE | Bayer CropScience Aktiengesellschaft (DE) | 2018-10-17 | — | — | EP | disclosed |
| WO-2017097882-A1 | LIQUID FORMULATIONS CONTAINING PROTHIOCONAZOLE | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2017-06-15 | — | — | WO | disclosed |
| EP-1973906-A1 | HYDROXYDIHYDROPYRIDOPY RAZINE-1,8-DIONES AND METHODS FOR INHIBITING HIV INTEGRASE | Virochem Pharma Inc. (CA) | 2008-10-01 | — | — | EP | disclosed |
| US-7407963-B2 | Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2008-08-05 | — | — | US | disclosed |
| US-20070054084-A1 | Optical recording medium and compound used for the same | MITSUI CHEMICALS, INC. (JP) | 2007-03-08 | — | — | US | disclosed |
| CN-1867980-A | Optical recording medium and compound for use in the same | MITSUI CHEMICALS INC (JP) | 2006-11-22 | — | — | CN | disclosed |
| WO-2006066414-A1 | HYDROXYDIHYDROPYRIDOPY RAZINE-1,8-DIONES AND METHODS FOR INHIBITING HIV INTEGRASE | VIROCHEM PHARMA INC. (CA) | 2006-06-29 | — | — | WO | disclosed |
| EP-1672626-A1 | OPTICAL RECORDING MEDIUM AND COMPOUND USED IN THE OPTICAL RECORDING MEDIUM | Mitsui Chemicals, Inc. (JP) | 2006-06-21 | — | — | EP | disclosed |
| US-20050267137-A1 | Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2005-12-01 | — | — | US | disclosed |
| EP-1228059-B1 | NOVEL CYCLOPROPANES AS CGRP ANTAGONISTS, MEDICAMENTS CONTAINING SAID COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF | BOEHRINGER INGELHEIM PHARMA (DE) | 2005-08-03 | — | — | EP | disclosed |
| US-20030139417-A1 | Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2003-07-24 | — | — | US | disclosed |